nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—MMP2—ovarian cancer	0.36	0.546	CbGaD
Captopril—MMP9—ovarian cancer	0.237	0.359	CbGaD
Captopril—ABCB1—ovarian cancer	0.0629	0.0953	CbGaD
Captopril—ABCB1—Topotecan—ovarian cancer	0.0177	0.267	CbGbCtD
Captopril—ABCB1—Vinorelbine—ovarian cancer	0.0125	0.188	CbGbCtD
Captopril—CYP2D6—Vinorelbine—ovarian cancer	0.0118	0.178	CbGbCtD
Captopril—REN—vein—ovarian cancer	0.00929	0.101	CbGeAlD
Captopril—ABCB1—Paclitaxel—ovarian cancer	0.00877	0.132	CbGbCtD
Captopril—F2—vein—ovarian cancer	0.00648	0.0704	CbGeAlD
Captopril—ABCB1—Docetaxel—ovarian cancer	0.00634	0.0957	CbGbCtD
Captopril—MMP2—oviduct—ovarian cancer	0.00525	0.057	CbGeAlD
Captopril—ABCB1—Doxorubicin—ovarian cancer	0.00473	0.0713	CbGbCtD
Captopril—CYP2D6—Doxorubicin—ovarian cancer	0.00445	0.0672	CbGbCtD
Captopril—ACE—vein—ovarian cancer	0.00396	0.043	CbGeAlD
Captopril—LTA4H—myometrium—ovarian cancer	0.00237	0.0257	CbGeAlD
Captopril—LTA4H—embryo—ovarian cancer	0.00228	0.0247	CbGeAlD
Captopril—LTA4H—uterine cervix—ovarian cancer	0.00184	0.02	CbGeAlD
Captopril—REN—myometrium—ovarian cancer	0.00183	0.0199	CbGeAlD
Captopril—LTA4H—decidua—ovarian cancer	0.00176	0.0191	CbGeAlD
Captopril—MMP2—myometrium—ovarian cancer	0.00168	0.0183	CbGeAlD
Captopril—LTA4H—endometrium—ovarian cancer	0.00167	0.0181	CbGeAlD
Captopril—MMP2—embryo—ovarian cancer	0.00162	0.0176	CbGeAlD
Captopril—LTA4H—gonad—ovarian cancer	0.00155	0.0168	CbGeAlD
Captopril—LTA4H—uterus—ovarian cancer	0.00154	0.0167	CbGeAlD
Captopril—REN—epithelium—ovarian cancer	0.00143	0.0156	CbGeAlD
Captopril—MMP9—embryo—ovarian cancer	0.00141	0.0153	CbGeAlD
Captopril—LTA4H—female reproductive system—ovarian cancer	0.00138	0.015	CbGeAlD
Captopril—REN—decidua—ovarian cancer	0.00136	0.0147	CbGeAlD
Captopril—MMP2—epithelium—ovarian cancer	0.00132	0.0143	CbGeAlD
Captopril—MMP2—uterine cervix—ovarian cancer	0.00131	0.0142	CbGeAlD
Captopril—LTA4H—bone marrow—ovarian cancer	0.0013	0.0142	CbGeAlD
Captopril—REN—endometrium—ovarian cancer	0.00129	0.014	CbGeAlD
Captopril—LTA4H—female gonad—ovarian cancer	0.00126	0.0136	CbGeAlD
Captopril—LTA4H—vagina—ovarian cancer	0.00125	0.0136	CbGeAlD
Captopril—MMP2—decidua—ovarian cancer	0.00125	0.0135	CbGeAlD
Captopril—MMP2—endometrium—ovarian cancer	0.00118	0.0128	CbGeAlD
Captopril—MMP9—epithelium—ovarian cancer	0.00115	0.0125	CbGeAlD
Captopril—MMP9—uterine cervix—ovarian cancer	0.00114	0.0124	CbGeAlD
Captopril—LTA4H—testis—ovarian cancer	0.00111	0.0121	CbGeAlD
Captopril—MMP2—gonad—ovarian cancer	0.0011	0.0119	CbGeAlD
Captopril—MMP2—uterus—ovarian cancer	0.00109	0.0118	CbGeAlD
Captopril—MMP9—decidua—ovarian cancer	0.00108	0.0118	CbGeAlD
Captopril—REN—female reproductive system—ovarian cancer	0.00107	0.0116	CbGeAlD
Captopril—MMP9—endometrium—ovarian cancer	0.00103	0.0112	CbGeAlD
Captopril—F2—epithelium—ovarian cancer	0.001	0.0109	CbGeAlD
Captopril—MMP2—female reproductive system—ovarian cancer	0.00098	0.0106	CbGeAlD
Captopril—REN—female gonad—ovarian cancer	0.00097	0.0105	CbGeAlD
Captopril—MMP9—uterus—ovarian cancer	0.000948	0.0103	CbGeAlD
Captopril—MMP2—female gonad—ovarian cancer	0.000892	0.00968	CbGeAlD
Captopril—MMP2—vagina—ovarian cancer	0.000886	0.00962	CbGeAlD
Captopril—SLC15A1—epithelium—ovarian cancer	0.000853	0.00926	CbGeAlD
Captopril—MMP9—female reproductive system—ovarian cancer	0.000852	0.00925	CbGeAlD
Captopril—LTA4H—lymph node—ovarian cancer	0.000808	0.00877	CbGeAlD
Captopril—MMP9—bone marrow—ovarian cancer	0.000804	0.00874	CbGeAlD
Captopril—MMP2—testis—ovarian cancer	0.000791	0.00859	CbGeAlD
Captopril—MMP9—female gonad—ovarian cancer	0.000775	0.00842	CbGeAlD
Captopril—SLC15A1—endometrium—ovarian cancer	0.000765	0.00831	CbGeAlD
Captopril—ACE—embryo—ovarian cancer	0.000749	0.00814	CbGeAlD
Captopril—F2—female reproductive system—ovarian cancer	0.000744	0.00807	CbGeAlD
Captopril—F2—bone marrow—ovarian cancer	0.000702	0.00762	CbGeAlD
Captopril—MMP9—testis—ovarian cancer	0.000688	0.00747	CbGeAlD
Captopril—F2—female gonad—ovarian cancer	0.000677	0.00735	CbGeAlD
Captopril—ACE—epithelium—ovarian cancer	0.000611	0.00664	CbGeAlD
Captopril—ACE—decidua—ovarian cancer	0.000578	0.00627	CbGeAlD
Captopril—MMP2—lymph node—ovarian cancer	0.000573	0.00622	CbGeAlD
Captopril—SLC15A1—vagina—ovarian cancer	0.000573	0.00622	CbGeAlD
Captopril—ACE—endometrium—ovarian cancer	0.000548	0.00595	CbGeAlD
Captopril—ACE—gonad—ovarian cancer	0.000509	0.00552	CbGeAlD
Captopril—MMP9—lymph node—ovarian cancer	0.000498	0.00541	CbGeAlD
Captopril—ACE—female reproductive system—ovarian cancer	0.000454	0.00493	CbGeAlD
Captopril—ACE—bone marrow—ovarian cancer	0.000429	0.00466	CbGeAlD
Captopril—ACE—female gonad—ovarian cancer	0.000413	0.00449	CbGeAlD
Captopril—ALB—testis—ovarian cancer	0.000383	0.00416	CbGeAlD
Captopril—ACE—testis—ovarian cancer	0.000367	0.00398	CbGeAlD
Captopril—ALB—lymph node—ovarian cancer	0.000278	0.00301	CbGeAlD
Captopril—ABCB1—myometrium—ovarian cancer	0.000274	0.00298	CbGeAlD
Captopril—ACE—lymph node—ovarian cancer	0.000266	0.00289	CbGeAlD
Captopril—ABCB1—embryo—ovarian cancer	0.000264	0.00286	CbGeAlD
Captopril—CYP2D6—female reproductive system—ovarian cancer	0.000222	0.00241	CbGeAlD
Captopril—ABCB1—epithelium—ovarian cancer	0.000215	0.00234	CbGeAlD
Captopril—ABCB1—uterine cervix—ovarian cancer	0.000213	0.00232	CbGeAlD
Captopril—ABCB1—decidua—ovarian cancer	0.000203	0.00221	CbGeAlD
Captopril—CYP2D6—female gonad—ovarian cancer	0.000202	0.0022	CbGeAlD
Captopril—ABCB1—endometrium—ovarian cancer	0.000193	0.0021	CbGeAlD
Captopril—CYP2D6—testis—ovarian cancer	0.000179	0.00195	CbGeAlD
Captopril—ABCB1—gonad—ovarian cancer	0.000179	0.00194	CbGeAlD
Captopril—ABCB1—uterus—ovarian cancer	0.000178	0.00193	CbGeAlD
Captopril—ABCB1—female reproductive system—ovarian cancer	0.00016	0.00174	CbGeAlD
Captopril—Body temperature increased—Vinorelbine—ovarian cancer	0.000151	0.00154	CcSEcCtD
Captopril—ABCB1—bone marrow—ovarian cancer	0.000151	0.00164	CbGeAlD
Captopril—Hyponatraemia—Epirubicin—ovarian cancer	0.00015	0.00153	CcSEcCtD
Captopril—Renal failure acute—Doxorubicin—ovarian cancer	0.00015	0.00152	CcSEcCtD
Captopril—Diarrhoea—Melphalan—ovarian cancer	0.00015	0.00152	CcSEcCtD
Captopril—Nausea—Chlorambucil—ovarian cancer	0.000149	0.00152	CcSEcCtD
Captopril—Vision blurred—Paclitaxel—ovarian cancer	0.000149	0.00151	CcSEcCtD
Captopril—Dizziness—Topotecan—ovarian cancer	0.000148	0.0015	CcSEcCtD
Captopril—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.000147	0.00149	CcSEcCtD
Captopril—Ill-defined disorder—Paclitaxel—ovarian cancer	0.000146	0.00149	CcSEcCtD
Captopril—Anaemia—Paclitaxel—ovarian cancer	0.000146	0.00148	CcSEcCtD
Captopril—ABCB1—female gonad—ovarian cancer	0.000145	0.00158	CbGeAlD
Captopril—Erythema multiforme—Docetaxel—ovarian cancer	0.000145	0.00148	CcSEcCtD
Captopril—Dermatitis bullous—Doxorubicin—ovarian cancer	0.000145	0.00147	CcSEcCtD
Captopril—ABCB1—vagina—ovarian cancer	0.000145	0.00157	CbGeAlD
Captopril—Angioedema—Paclitaxel—ovarian cancer	0.000144	0.00146	CcSEcCtD
Captopril—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.000143	0.00145	CcSEcCtD
Captopril—Flushing—Docetaxel—ovarian cancer	0.000143	0.00145	CcSEcCtD
Captopril—Cardiac arrest—Epirubicin—ovarian cancer	0.000143	0.00145	CcSEcCtD
Captopril—Vomiting—Topotecan—ovarian cancer	0.000142	0.00145	CcSEcCtD
Captopril—Malaise—Paclitaxel—ovarian cancer	0.000142	0.00145	CcSEcCtD
Captopril—Syncope—Paclitaxel—ovarian cancer	0.000142	0.00144	CcSEcCtD
Captopril—Cerebrovascular accident—Doxorubicin—ovarian cancer	0.000142	0.00144	CcSEcCtD
Captopril—Rash—Topotecan—ovarian cancer	0.000141	0.00143	CcSEcCtD
Captopril—Dermatitis—Topotecan—ovarian cancer	0.000141	0.00143	CcSEcCtD
Captopril—Ataxia—Epirubicin—ovarian cancer	0.000141	0.00143	CcSEcCtD
Captopril—Headache—Topotecan—ovarian cancer	0.00014	0.00142	CcSEcCtD
Captopril—Palpitations—Paclitaxel—ovarian cancer	0.00014	0.00142	CcSEcCtD
Captopril—Vomiting—Melphalan—ovarian cancer	0.000139	0.00142	CcSEcCtD
Captopril—Hyponatraemia—Doxorubicin—ovarian cancer	0.000139	0.00141	CcSEcCtD
Captopril—Loss of consciousness—Paclitaxel—ovarian cancer	0.000139	0.00141	CcSEcCtD
Captopril—Rash—Melphalan—ovarian cancer	0.000138	0.0014	CcSEcCtD
Captopril—Dermatitis—Melphalan—ovarian cancer	0.000138	0.0014	CcSEcCtD
Captopril—Cough—Paclitaxel—ovarian cancer	0.000138	0.0014	CcSEcCtD
Captopril—Asthenia—Vinorelbine—ovarian cancer	0.000137	0.0014	CcSEcCtD
Captopril—Orthostatic hypotension—Epirubicin—ovarian cancer	0.000137	0.00139	CcSEcCtD
Captopril—Alopecia—Docetaxel—ovarian cancer	0.000136	0.00138	CcSEcCtD
Captopril—Pruritus—Vinorelbine—ovarian cancer	0.000136	0.00138	CcSEcCtD
Captopril—Chest pain—Paclitaxel—ovarian cancer	0.000134	0.00136	CcSEcCtD
Captopril—Myalgia—Paclitaxel—ovarian cancer	0.000134	0.00136	CcSEcCtD
Captopril—Arthralgia—Paclitaxel—ovarian cancer	0.000134	0.00136	CcSEcCtD
Captopril—Nausea—Topotecan—ovarian cancer	0.000133	0.00135	CcSEcCtD
Captopril—Discomfort—Paclitaxel—ovarian cancer	0.000133	0.00135	CcSEcCtD
Captopril—Muscular weakness—Epirubicin—ovarian cancer	0.000132	0.00134	CcSEcCtD
Captopril—Cardiac arrest—Doxorubicin—ovarian cancer	0.000132	0.00134	CcSEcCtD
Captopril—Dry mouth—Paclitaxel—ovarian cancer	0.000131	0.00133	CcSEcCtD
Captopril—Diarrhoea—Vinorelbine—ovarian cancer	0.000131	0.00133	CcSEcCtD
Captopril—Dysgeusia—Docetaxel—ovarian cancer	0.000131	0.00133	CcSEcCtD
Captopril—Ataxia—Doxorubicin—ovarian cancer	0.00013	0.00132	CcSEcCtD
Captopril—Nausea—Melphalan—ovarian cancer	0.00013	0.00132	CcSEcCtD
Captopril—Confusional state—Paclitaxel—ovarian cancer	0.00013	0.00132	CcSEcCtD
Captopril—ABCB1—testis—ovarian cancer	0.000129	0.0014	CbGeAlD
Captopril—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000129	0.00131	CcSEcCtD
Captopril—Eosinophilia—Epirubicin—ovarian cancer	0.000128	0.0013	CcSEcCtD
Captopril—Pancreatitis—Epirubicin—ovarian cancer	0.000127	0.00129	CcSEcCtD
Captopril—Shock—Paclitaxel—ovarian cancer	0.000127	0.00129	CcSEcCtD
Captopril—Dizziness—Vinorelbine—ovarian cancer	0.000127	0.00129	CcSEcCtD
Captopril—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.000127	0.00129	CcSEcCtD
Captopril—Angina pectoris—Epirubicin—ovarian cancer	0.000126	0.00128	CcSEcCtD
Captopril—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000126	0.00128	CcSEcCtD
Captopril—Tachycardia—Paclitaxel—ovarian cancer	0.000126	0.00128	CcSEcCtD
Captopril—Anaemia—Docetaxel—ovarian cancer	0.000124	0.00126	CcSEcCtD
Captopril—Pancytopenia—Epirubicin—ovarian cancer	0.000123	0.00125	CcSEcCtD
Captopril—Anorexia—Paclitaxel—ovarian cancer	0.000123	0.00125	CcSEcCtD
Captopril—Muscular weakness—Doxorubicin—ovarian cancer	0.000122	0.00124	CcSEcCtD
Captopril—Vomiting—Vinorelbine—ovarian cancer	0.000122	0.00124	CcSEcCtD
Captopril—Neutropenia—Epirubicin—ovarian cancer	0.000121	0.00123	CcSEcCtD
Captopril—Rash—Vinorelbine—ovarian cancer	0.000121	0.00123	CcSEcCtD
Captopril—Dermatitis—Vinorelbine—ovarian cancer	0.000121	0.00122	CcSEcCtD
Captopril—Hypotension—Paclitaxel—ovarian cancer	0.00012	0.00122	CcSEcCtD
Captopril—Headache—Vinorelbine—ovarian cancer	0.00012	0.00122	CcSEcCtD
Captopril—Syncope—Docetaxel—ovarian cancer	0.00012	0.00122	CcSEcCtD
Captopril—Pollakiuria—Epirubicin—ovarian cancer	0.00012	0.00121	CcSEcCtD
Captopril—Eosinophilia—Doxorubicin—ovarian cancer	0.000119	0.0012	CcSEcCtD
Captopril—Palpitations—Docetaxel—ovarian cancer	0.000118	0.0012	CcSEcCtD
Captopril—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000118	0.0012	CcSEcCtD
Captopril—Loss of consciousness—Docetaxel—ovarian cancer	0.000118	0.00119	CcSEcCtD
Captopril—Pancreatitis—Doxorubicin—ovarian cancer	0.000118	0.00119	CcSEcCtD
Captopril—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000117	0.00119	CcSEcCtD
Captopril—Weight decreased—Epirubicin—ovarian cancer	0.000117	0.00119	CcSEcCtD
Captopril—Cough—Docetaxel—ovarian cancer	0.000117	0.00119	CcSEcCtD
Captopril—Angina pectoris—Doxorubicin—ovarian cancer	0.000117	0.00119	CcSEcCtD
Captopril—Insomnia—Paclitaxel—ovarian cancer	0.000117	0.00118	CcSEcCtD
Captopril—Paraesthesia—Paclitaxel—ovarian cancer	0.000116	0.00117	CcSEcCtD
Captopril—Dyspnoea—Paclitaxel—ovarian cancer	0.000115	0.00117	CcSEcCtD
Captopril—Somnolence—Paclitaxel—ovarian cancer	0.000115	0.00116	CcSEcCtD
Captopril—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000115	0.00116	CcSEcCtD
Captopril—Arthralgia—Docetaxel—ovarian cancer	0.000114	0.00116	CcSEcCtD
Captopril—Myalgia—Docetaxel—ovarian cancer	0.000114	0.00116	CcSEcCtD
Captopril—Chest pain—Docetaxel—ovarian cancer	0.000114	0.00116	CcSEcCtD
Captopril—Pancytopenia—Doxorubicin—ovarian cancer	0.000114	0.00116	CcSEcCtD
Captopril—Nausea—Vinorelbine—ovarian cancer	0.000114	0.00115	CcSEcCtD
Captopril—Renal failure—Epirubicin—ovarian cancer	0.000114	0.00115	CcSEcCtD
Captopril—Dyspepsia—Paclitaxel—ovarian cancer	0.000113	0.00115	CcSEcCtD
Captopril—Jaundice—Epirubicin—ovarian cancer	0.000113	0.00114	CcSEcCtD
Captopril—Stomatitis—Epirubicin—ovarian cancer	0.000113	0.00114	CcSEcCtD
Captopril—Neutropenia—Doxorubicin—ovarian cancer	0.000112	0.00114	CcSEcCtD
Captopril—Decreased appetite—Paclitaxel—ovarian cancer	0.000112	0.00114	CcSEcCtD
Captopril—Dry mouth—Docetaxel—ovarian cancer	0.000111	0.00113	CcSEcCtD
Captopril—Fatigue—Paclitaxel—ovarian cancer	0.000111	0.00113	CcSEcCtD
Captopril—Pollakiuria—Doxorubicin—ovarian cancer	0.000111	0.00112	CcSEcCtD
Captopril—Constipation—Paclitaxel—ovarian cancer	0.00011	0.00112	CcSEcCtD
Captopril—Confusional state—Docetaxel—ovarian cancer	0.00011	0.00112	CcSEcCtD
Captopril—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000109	0.00111	CcSEcCtD
Captopril—Anaphylactic shock—Docetaxel—ovarian cancer	0.000109	0.00111	CcSEcCtD
Captopril—Weight decreased—Doxorubicin—ovarian cancer	0.000108	0.0011	CcSEcCtD
Captopril—Agranulocytosis—Epirubicin—ovarian cancer	0.000108	0.00109	CcSEcCtD
Captopril—Shock—Docetaxel—ovarian cancer	0.000107	0.00109	CcSEcCtD
Captopril—Thrombocytopenia—Docetaxel—ovarian cancer	0.000107	0.00109	CcSEcCtD
Captopril—Tachycardia—Docetaxel—ovarian cancer	0.000107	0.00108	CcSEcCtD
Captopril—Feeling abnormal—Paclitaxel—ovarian cancer	0.000106	0.00108	CcSEcCtD
Captopril—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000106	0.00108	CcSEcCtD
Captopril—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000105	0.00107	CcSEcCtD
Captopril—Renal failure—Doxorubicin—ovarian cancer	0.000105	0.00107	CcSEcCtD
Captopril—Stomatitis—Doxorubicin—ovarian cancer	0.000104	0.00106	CcSEcCtD
Captopril—Jaundice—Doxorubicin—ovarian cancer	0.000104	0.00106	CcSEcCtD
Captopril—Anorexia—Docetaxel—ovarian cancer	0.000104	0.00106	CcSEcCtD
Captopril—Rhinitis—Epirubicin—ovarian cancer	0.000104	0.00106	CcSEcCtD
Captopril—Hepatitis—Epirubicin—ovarian cancer	0.000104	0.00105	CcSEcCtD
Captopril—Pharyngitis—Epirubicin—ovarian cancer	0.000103	0.00104	CcSEcCtD
Captopril—Hypotension—Docetaxel—ovarian cancer	0.000102	0.00104	CcSEcCtD
Captopril—Abdominal pain—Paclitaxel—ovarian cancer	0.000102	0.00103	CcSEcCtD
Captopril—Body temperature increased—Paclitaxel—ovarian cancer	0.000102	0.00103	CcSEcCtD
Captopril—Agranulocytosis—Doxorubicin—ovarian cancer	9.97e-05	0.00101	CcSEcCtD
Captopril—Musculoskeletal discomfort—Docetaxel—ovarian cancer	9.95e-05	0.00101	CcSEcCtD
Captopril—Insomnia—Docetaxel—ovarian cancer	9.88e-05	0.001	CcSEcCtD
Captopril—Paraesthesia—Docetaxel—ovarian cancer	9.81e-05	0.000995	CcSEcCtD
Captopril—Erythema multiforme—Epirubicin—ovarian cancer	9.8e-05	0.000995	CcSEcCtD
Captopril—Dyspnoea—Docetaxel—ovarian cancer	9.74e-05	0.000988	CcSEcCtD
Captopril—Somnolence—Docetaxel—ovarian cancer	9.71e-05	0.000986	CcSEcCtD
Captopril—Flushing—Epirubicin—ovarian cancer	9.62e-05	0.000977	CcSEcCtD
Captopril—Rhinitis—Doxorubicin—ovarian cancer	9.62e-05	0.000976	CcSEcCtD
Captopril—Dyspepsia—Docetaxel—ovarian cancer	9.61e-05	0.000976	CcSEcCtD
Captopril—Hepatitis—Doxorubicin—ovarian cancer	9.59e-05	0.000974	CcSEcCtD
Captopril—Pharyngitis—Doxorubicin—ovarian cancer	9.52e-05	0.000967	CcSEcCtD
Captopril—Decreased appetite—Docetaxel—ovarian cancer	9.49e-05	0.000964	CcSEcCtD
Captopril—Fatigue—Docetaxel—ovarian cancer	9.42e-05	0.000956	CcSEcCtD
Captopril—ABCB1—lymph node—ovarian cancer	9.35e-05	0.00102	CbGeAlD
Captopril—Constipation—Docetaxel—ovarian cancer	9.34e-05	0.000948	CcSEcCtD
Captopril—Asthenia—Paclitaxel—ovarian cancer	9.24e-05	0.000938	CcSEcCtD
Captopril—Alopecia—Epirubicin—ovarian cancer	9.16e-05	0.00093	CcSEcCtD
Captopril—Pruritus—Paclitaxel—ovarian cancer	9.12e-05	0.000925	CcSEcCtD
Captopril—Erythema multiforme—Doxorubicin—ovarian cancer	9.07e-05	0.000921	CcSEcCtD
Captopril—Feeling abnormal—Docetaxel—ovarian cancer	9e-05	0.000914	CcSEcCtD
Captopril—Gastrointestinal pain—Docetaxel—ovarian cancer	8.93e-05	0.000907	CcSEcCtD
Captopril—Flushing—Doxorubicin—ovarian cancer	8.9e-05	0.000904	CcSEcCtD
Captopril—Tension—Epirubicin—ovarian cancer	8.86e-05	0.000899	CcSEcCtD
Captopril—Dysgeusia—Epirubicin—ovarian cancer	8.84e-05	0.000897	CcSEcCtD
Captopril—Diarrhoea—Paclitaxel—ovarian cancer	8.82e-05	0.000895	CcSEcCtD
Captopril—Nervousness—Epirubicin—ovarian cancer	8.77e-05	0.00089	CcSEcCtD
Captopril—Abdominal pain—Docetaxel—ovarian cancer	8.63e-05	0.000876	CcSEcCtD
Captopril—Body temperature increased—Docetaxel—ovarian cancer	8.63e-05	0.000876	CcSEcCtD
Captopril—Dizziness—Paclitaxel—ovarian cancer	8.52e-05	0.000865	CcSEcCtD
Captopril—Vision blurred—Epirubicin—ovarian cancer	8.51e-05	0.000863	CcSEcCtD
Captopril—Alopecia—Doxorubicin—ovarian cancer	8.48e-05	0.000861	CcSEcCtD
Captopril—Ill-defined disorder—Epirubicin—ovarian cancer	8.37e-05	0.00085	CcSEcCtD
Captopril—Anaemia—Epirubicin—ovarian cancer	8.34e-05	0.000847	CcSEcCtD
Captopril—Tension—Doxorubicin—ovarian cancer	8.2e-05	0.000832	CcSEcCtD
Captopril—Vomiting—Paclitaxel—ovarian cancer	8.19e-05	0.000832	CcSEcCtD
Captopril—Dysgeusia—Doxorubicin—ovarian cancer	8.18e-05	0.00083	CcSEcCtD
Captopril—Malaise—Epirubicin—ovarian cancer	8.14e-05	0.000826	CcSEcCtD
Captopril—Rash—Paclitaxel—ovarian cancer	8.12e-05	0.000825	CcSEcCtD
Captopril—Dermatitis—Paclitaxel—ovarian cancer	8.12e-05	0.000824	CcSEcCtD
Captopril—Nervousness—Doxorubicin—ovarian cancer	8.11e-05	0.000823	CcSEcCtD
Captopril—Syncope—Epirubicin—ovarian cancer	8.09e-05	0.000822	CcSEcCtD
Captopril—Headache—Paclitaxel—ovarian cancer	8.07e-05	0.000819	CcSEcCtD
Captopril—Palpitations—Epirubicin—ovarian cancer	7.98e-05	0.00081	CcSEcCtD
Captopril—Loss of consciousness—Epirubicin—ovarian cancer	7.93e-05	0.000805	CcSEcCtD
Captopril—Cough—Epirubicin—ovarian cancer	7.88e-05	0.000799	CcSEcCtD
Captopril—Vision blurred—Doxorubicin—ovarian cancer	7.87e-05	0.000799	CcSEcCtD
Captopril—Asthenia—Docetaxel—ovarian cancer	7.84e-05	0.000795	CcSEcCtD
Captopril—Ill-defined disorder—Doxorubicin—ovarian cancer	7.75e-05	0.000787	CcSEcCtD
Captopril—Pruritus—Docetaxel—ovarian cancer	7.73e-05	0.000784	CcSEcCtD
Captopril—Anaemia—Doxorubicin—ovarian cancer	7.72e-05	0.000784	CcSEcCtD
Captopril—Myalgia—Epirubicin—ovarian cancer	7.68e-05	0.00078	CcSEcCtD
Captopril—Arthralgia—Epirubicin—ovarian cancer	7.68e-05	0.00078	CcSEcCtD
Captopril—Chest pain—Epirubicin—ovarian cancer	7.68e-05	0.00078	CcSEcCtD
Captopril—Nausea—Paclitaxel—ovarian cancer	7.65e-05	0.000777	CcSEcCtD
Captopril—Discomfort—Epirubicin—ovarian cancer	7.59e-05	0.000771	CcSEcCtD
Captopril—Malaise—Doxorubicin—ovarian cancer	7.53e-05	0.000764	CcSEcCtD
Captopril—Dry mouth—Epirubicin—ovarian cancer	7.52e-05	0.000763	CcSEcCtD
Captopril—Syncope—Doxorubicin—ovarian cancer	7.49e-05	0.00076	CcSEcCtD
Captopril—Diarrhoea—Docetaxel—ovarian cancer	7.47e-05	0.000758	CcSEcCtD
Captopril—Confusional state—Epirubicin—ovarian cancer	7.43e-05	0.000754	CcSEcCtD
Captopril—Palpitations—Doxorubicin—ovarian cancer	7.38e-05	0.000749	CcSEcCtD
Captopril—Anaphylactic shock—Epirubicin—ovarian cancer	7.37e-05	0.000748	CcSEcCtD
Captopril—Loss of consciousness—Doxorubicin—ovarian cancer	7.34e-05	0.000745	CcSEcCtD
Captopril—Cough—Doxorubicin—ovarian cancer	7.29e-05	0.00074	CcSEcCtD
Captopril—Shock—Epirubicin—ovarian cancer	7.25e-05	0.000736	CcSEcCtD
Captopril—Dizziness—Docetaxel—ovarian cancer	7.22e-05	0.000733	CcSEcCtD
Captopril—Thrombocytopenia—Epirubicin—ovarian cancer	7.21e-05	0.000732	CcSEcCtD
Captopril—Tachycardia—Epirubicin—ovarian cancer	7.19e-05	0.00073	CcSEcCtD
Captopril—Myalgia—Doxorubicin—ovarian cancer	7.11e-05	0.000722	CcSEcCtD
Captopril—Arthralgia—Doxorubicin—ovarian cancer	7.11e-05	0.000722	CcSEcCtD
Captopril—Chest pain—Doxorubicin—ovarian cancer	7.11e-05	0.000722	CcSEcCtD
Captopril—Discomfort—Doxorubicin—ovarian cancer	7.02e-05	0.000713	CcSEcCtD
Captopril—Anorexia—Epirubicin—ovarian cancer	7.02e-05	0.000713	CcSEcCtD
Captopril—Dry mouth—Doxorubicin—ovarian cancer	6.95e-05	0.000706	CcSEcCtD
Captopril—Vomiting—Docetaxel—ovarian cancer	6.94e-05	0.000705	CcSEcCtD
Captopril—Rash—Docetaxel—ovarian cancer	6.89e-05	0.000699	CcSEcCtD
Captopril—Hypotension—Epirubicin—ovarian cancer	6.88e-05	0.000699	CcSEcCtD
Captopril—Dermatitis—Docetaxel—ovarian cancer	6.88e-05	0.000698	CcSEcCtD
Captopril—Confusional state—Doxorubicin—ovarian cancer	6.87e-05	0.000698	CcSEcCtD
Captopril—Headache—Docetaxel—ovarian cancer	6.84e-05	0.000694	CcSEcCtD
Captopril—Anaphylactic shock—Doxorubicin—ovarian cancer	6.82e-05	0.000692	CcSEcCtD
Captopril—Musculoskeletal discomfort—Epirubicin—ovarian cancer	6.71e-05	0.000681	CcSEcCtD
Captopril—Shock—Doxorubicin—ovarian cancer	6.71e-05	0.000681	CcSEcCtD
Captopril—Thrombocytopenia—Doxorubicin—ovarian cancer	6.67e-05	0.000677	CcSEcCtD
Captopril—Insomnia—Epirubicin—ovarian cancer	6.66e-05	0.000676	CcSEcCtD
Captopril—Tachycardia—Doxorubicin—ovarian cancer	6.65e-05	0.000675	CcSEcCtD
Captopril—Paraesthesia—Epirubicin—ovarian cancer	6.61e-05	0.000671	CcSEcCtD
Captopril—Dyspnoea—Epirubicin—ovarian cancer	6.57e-05	0.000667	CcSEcCtD
Captopril—Somnolence—Epirubicin—ovarian cancer	6.55e-05	0.000665	CcSEcCtD
Captopril—Anorexia—Doxorubicin—ovarian cancer	6.5e-05	0.000659	CcSEcCtD
Captopril—Nausea—Docetaxel—ovarian cancer	6.49e-05	0.000658	CcSEcCtD
Captopril—Dyspepsia—Epirubicin—ovarian cancer	6.48e-05	0.000658	CcSEcCtD
Captopril—Decreased appetite—Epirubicin—ovarian cancer	6.4e-05	0.00065	CcSEcCtD
Captopril—Hypotension—Doxorubicin—ovarian cancer	6.37e-05	0.000646	CcSEcCtD
Captopril—Fatigue—Epirubicin—ovarian cancer	6.35e-05	0.000645	CcSEcCtD
Captopril—Constipation—Epirubicin—ovarian cancer	6.3e-05	0.000639	CcSEcCtD
Captopril—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	6.21e-05	0.00063	CcSEcCtD
Captopril—Insomnia—Doxorubicin—ovarian cancer	6.16e-05	0.000626	CcSEcCtD
Captopril—Paraesthesia—Doxorubicin—ovarian cancer	6.12e-05	0.000621	CcSEcCtD
Captopril—Dyspnoea—Doxorubicin—ovarian cancer	6.08e-05	0.000617	CcSEcCtD
Captopril—Feeling abnormal—Epirubicin—ovarian cancer	6.07e-05	0.000616	CcSEcCtD
Captopril—Somnolence—Doxorubicin—ovarian cancer	6.06e-05	0.000615	CcSEcCtD
Captopril—Gastrointestinal pain—Epirubicin—ovarian cancer	6.02e-05	0.000611	CcSEcCtD
Captopril—Dyspepsia—Doxorubicin—ovarian cancer	6e-05	0.000609	CcSEcCtD
Captopril—Decreased appetite—Doxorubicin—ovarian cancer	5.93e-05	0.000601	CcSEcCtD
Captopril—Fatigue—Doxorubicin—ovarian cancer	5.88e-05	0.000596	CcSEcCtD
Captopril—Constipation—Doxorubicin—ovarian cancer	5.83e-05	0.000592	CcSEcCtD
Captopril—Body temperature increased—Epirubicin—ovarian cancer	5.82e-05	0.000591	CcSEcCtD
Captopril—Abdominal pain—Epirubicin—ovarian cancer	5.82e-05	0.000591	CcSEcCtD
Captopril—Feeling abnormal—Doxorubicin—ovarian cancer	5.62e-05	0.00057	CcSEcCtD
Captopril—Gastrointestinal pain—Doxorubicin—ovarian cancer	5.57e-05	0.000566	CcSEcCtD
Captopril—Abdominal pain—Doxorubicin—ovarian cancer	5.39e-05	0.000547	CcSEcCtD
Captopril—Body temperature increased—Doxorubicin—ovarian cancer	5.39e-05	0.000547	CcSEcCtD
Captopril—Asthenia—Epirubicin—ovarian cancer	5.29e-05	0.000536	CcSEcCtD
Captopril—Pruritus—Epirubicin—ovarian cancer	5.21e-05	0.000529	CcSEcCtD
Captopril—Diarrhoea—Epirubicin—ovarian cancer	5.04e-05	0.000512	CcSEcCtD
Captopril—Asthenia—Doxorubicin—ovarian cancer	4.89e-05	0.000496	CcSEcCtD
Captopril—Dizziness—Epirubicin—ovarian cancer	4.87e-05	0.000494	CcSEcCtD
Captopril—Pruritus—Doxorubicin—ovarian cancer	4.82e-05	0.000489	CcSEcCtD
Captopril—Vomiting—Epirubicin—ovarian cancer	4.68e-05	0.000475	CcSEcCtD
Captopril—Diarrhoea—Doxorubicin—ovarian cancer	4.66e-05	0.000473	CcSEcCtD
Captopril—Rash—Epirubicin—ovarian cancer	4.64e-05	0.000471	CcSEcCtD
Captopril—Dermatitis—Epirubicin—ovarian cancer	4.64e-05	0.000471	CcSEcCtD
Captopril—Headache—Epirubicin—ovarian cancer	4.61e-05	0.000468	CcSEcCtD
Captopril—Dizziness—Doxorubicin—ovarian cancer	4.51e-05	0.000458	CcSEcCtD
Captopril—Nausea—Epirubicin—ovarian cancer	4.38e-05	0.000444	CcSEcCtD
Captopril—Vomiting—Doxorubicin—ovarian cancer	4.33e-05	0.00044	CcSEcCtD
Captopril—Rash—Doxorubicin—ovarian cancer	4.3e-05	0.000436	CcSEcCtD
Captopril—Dermatitis—Doxorubicin—ovarian cancer	4.29e-05	0.000436	CcSEcCtD
Captopril—Headache—Doxorubicin—ovarian cancer	4.27e-05	0.000433	CcSEcCtD
Captopril—Nausea—Doxorubicin—ovarian cancer	4.05e-05	0.000411	CcSEcCtD
Captopril—ALB—Folate Metabolism—TP53—ovarian cancer	2.58e-05	0.000313	CbGpPWpGaD
Captopril—LTA4H—Metabolism—PIK3CA—ovarian cancer	2.56e-05	0.000311	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	2.55e-05	0.00031	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—CTNNB1—ovarian cancer	2.53e-05	0.000307	CbGpPWpGaD
Captopril—F2—Hemostasis—PIK3CD—ovarian cancer	2.48e-05	0.000301	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PGR—ovarian cancer	2.45e-05	0.000297	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—HRAS—ovarian cancer	2.45e-05	0.000297	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HDAC6—ovarian cancer	2.45e-05	0.000297	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—PPP2R1A—ovarian cancer	2.42e-05	0.000293	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ovarian cancer	2.42e-05	0.000293	CbGpPWpGaD
Captopril—ABCB1—Metabolism—NME2—ovarian cancer	2.39e-05	0.000289	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—IL6—ovarian cancer	2.36e-05	0.000286	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—IL6—ovarian cancer	2.35e-05	0.000285	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—CXCL8—ovarian cancer	2.32e-05	0.000282	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	2.31e-05	0.000281	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ovarian cancer	2.31e-05	0.00028	CbGpPWpGaD
Captopril—ALB—Hemostasis—SPARC—ovarian cancer	2.31e-05	0.00028	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	2.31e-05	0.00028	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PARP1—ovarian cancer	2.28e-05	0.000277	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	2.26e-05	0.000274	CbGpPWpGaD
Captopril—MMP9—Axon guidance—HRAS—ovarian cancer	2.25e-05	0.000273	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—NME2—ovarian cancer	2.25e-05	0.000273	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—VEGFA—ovarian cancer	2.23e-05	0.00027	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—STAT3—ovarian cancer	2.2e-05	0.000267	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—NRAS—ovarian cancer	2.2e-05	0.000267	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—PIK3CG—ovarian cancer	2.17e-05	0.000263	CbGpPWpGaD
Captopril—F2—Signaling Pathways—YAP1—ovarian cancer	2.17e-05	0.000263	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—AKT1—ovarian cancer	2.17e-05	0.000263	CbGpPWpGaD
Captopril—F2—Hemostasis—PIK3CB—ovarian cancer	2.16e-05	0.000262	CbGpPWpGaD
Captopril—MMP9—Axon guidance—IL6—ovarian cancer	2.16e-05	0.000262	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	2.14e-05	0.000259	CbGpPWpGaD
Captopril—F2—Signaling Pathways—XIAP—ovarian cancer	2.12e-05	0.000258	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—MAPK3—ovarian cancer	2.11e-05	0.000255	CbGpPWpGaD
Captopril—LTA4H—Metabolism—AKT1—ovarian cancer	2.09e-05	0.000254	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	2.09e-05	0.000253	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SMARCA4—ovarian cancer	2.07e-05	0.000251	CbGpPWpGaD
Captopril—F2—Signaling Pathways—EREG—ovarian cancer	2.02e-05	0.000245	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—MAPK1—ovarian cancer	2e-05	0.000243	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—EGFR—ovarian cancer	2e-05	0.000243	CbGpPWpGaD
Captopril—F2—Hemostasis—IL2—ovarian cancer	1.98e-05	0.000241	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—MMP2—ovarian cancer	1.96e-05	0.000238	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	1.91e-05	0.000231	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—PIK3CD—ovarian cancer	1.91e-05	0.000231	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PGR—ovarian cancer	1.89e-05	0.00023	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—KRAS—ovarian cancer	1.89e-05	0.00023	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.88e-05	0.000228	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—IL6—ovarian cancer	1.87e-05	0.000227	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PPP2R1A—ovarian cancer	1.85e-05	0.000224	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—PIK3CG—ovarian cancer	1.78e-05	0.000216	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.76e-05	0.000214	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PARP1—ovarian cancer	1.76e-05	0.000213	CbGpPWpGaD
Captopril—ALB—Metabolism—CYTB—ovarian cancer	1.76e-05	0.000213	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.72e-05	0.000208	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.7e-05	0.000206	CbGpPWpGaD
Captopril—F2—Hemostasis—VEGFA—ovarian cancer	1.69e-05	0.000204	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—IL6ST—ovarian cancer	1.68e-05	0.000204	CbGpPWpGaD
Captopril—ALB—Hemostasis—SOD1—ovarian cancer	1.68e-05	0.000204	CbGpPWpGaD
Captopril—ALB—Hemostasis—PPP2R1A—ovarian cancer	1.67e-05	0.000203	CbGpPWpGaD
Captopril—F2—Hemostasis—NRAS—ovarian cancer	1.67e-05	0.000202	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—PIK3CB—ovarian cancer	1.66e-05	0.000202	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	1.66e-05	0.000201	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—CXCL8—ovarian cancer	1.63e-05	0.000198	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—PIK3CG—ovarian cancer	1.62e-05	0.000196	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—HRAS—ovarian cancer	1.61e-05	0.000195	CbGpPWpGaD
Captopril—F2—Hemostasis—MAPK3—ovarian cancer	1.59e-05	0.000193	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—PIK3CD—ovarian cancer	1.57e-05	0.00019	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.54e-05	0.000187	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—IL6—ovarian cancer	1.54e-05	0.000187	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYTB—ovarian cancer	1.54e-05	0.000187	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	1.54e-05	0.000186	CbGpPWpGaD
Captopril—ALB—Metabolism—PPP1CC—ovarian cancer	1.53e-05	0.000186	CbGpPWpGaD
Captopril—ALB—Metabolism—BRIP1—ovarian cancer	1.53e-05	0.000186	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—IL2—ovarian cancer	1.53e-05	0.000185	CbGpPWpGaD
Captopril—F2—Hemostasis—MAPK1—ovarian cancer	1.52e-05	0.000184	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—CTNNB1—ovarian cancer	1.51e-05	0.000183	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	1.51e-05	0.000183	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.49e-05	0.000181	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TERT—ovarian cancer	1.47e-05	0.000178	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	1.47e-05	0.000178	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.45e-05	0.000176	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CYTB—ovarian cancer	1.45e-05	0.000176	CbGpPWpGaD
Captopril—F2—Hemostasis—KRAS—ovarian cancer	1.43e-05	0.000174	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PPP2R1A—ovarian cancer	1.43e-05	0.000173	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—PIK3CD—ovarian cancer	1.42e-05	0.000172	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—AKT1—ovarian cancer	1.42e-05	0.000172	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.41e-05	0.000172	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—PIK3CB—ovarian cancer	1.37e-05	0.000166	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CAV1—ovarian cancer	1.36e-05	0.000165	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PPP1CC—ovarian cancer	1.34e-05	0.000163	CbGpPWpGaD
Captopril—ABCB1—Metabolism—BRIP1—ovarian cancer	1.34e-05	0.000163	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.34e-05	0.000163	CbGpPWpGaD
Captopril—F2—Hemostasis—PIK3CA—ovarian cancer	1.32e-05	0.00016	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—CXCL8—ovarian cancer	1.31e-05	0.000159	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—ESR1—ovarian cancer	1.31e-05	0.000159	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	1.3e-05	0.000157	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IL6ST—ovarian cancer	1.29e-05	0.000156	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.28e-05	0.000155	CbGpPWpGaD
Captopril—F2—Hemostasis—TP53—ovarian cancer	1.27e-05	0.000155	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PPP1CC—ovarian cancer	1.27e-05	0.000154	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—BRIP1—ovarian cancer	1.27e-05	0.000154	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—IL2—ovarian cancer	1.25e-05	0.000152	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—PIK3CB—ovarian cancer	1.24e-05	0.00015	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—APC—ovarian cancer	1.24e-05	0.00015	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PIK3CG—ovarian cancer	1.24e-05	0.00015	CbGpPWpGaD
Captopril—ALB—Hemostasis—CAV1—ovarian cancer	1.23e-05	0.000149	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	1.23e-05	0.000149	CbGpPWpGaD
Captopril—F2—Hemostasis—HRAS—ovarian cancer	1.22e-05	0.000148	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.21e-05	0.000147	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CXCL8—ovarian cancer	1.19e-05	0.000144	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.18e-05	0.000143	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	1.17e-05	0.000142	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.15e-05	0.00014	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.15e-05	0.000139	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—IL2—ovarian cancer	1.14e-05	0.000138	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TERT—ovarian cancer	1.13e-05	0.000138	CbGpPWpGaD
Captopril—ALB—Hemostasis—PIK3CG—ovarian cancer	1.12e-05	0.000136	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.12e-05	0.000136	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PIK3CD—ovarian cancer	1.09e-05	0.000132	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.09e-05	0.000132	CbGpPWpGaD
Captopril—F2—Hemostasis—AKT1—ovarian cancer	1.08e-05	0.00013	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CAV1—ovarian cancer	1.05e-05	0.000127	CbGpPWpGaD
Captopril—ALB—Metabolism—YAP1—ovarian cancer	1.03e-05	0.000125	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.02e-05	0.000124	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	1.01e-05	0.000123	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ESR1—ovarian cancer	1.01e-05	0.000123	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	9.98e-06	0.000121	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IL6ST—ovarian cancer	9.95e-06	0.000121	CbGpPWpGaD
Captopril—ALB—Hemostasis—PIK3CD—ovarian cancer	9.83e-06	0.000119	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	9.65e-06	0.000117	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—ERBB2—ovarian cancer	9.61e-06	0.000117	CbGpPWpGaD
Captopril—F2—Signaling Pathways—APC—ovarian cancer	9.56e-06	0.000116	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PIK3CG—ovarian cancer	9.56e-06	0.000116	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—NRAS—ovarian cancer	9.56e-06	0.000116	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PIK3CB—ovarian cancer	9.48e-06	0.000115	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MTOR—ovarian cancer	9.48e-06	0.000115	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—MAPK3—ovarian cancer	9.15e-06	0.000111	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CXCL8—ovarian cancer	9.11e-06	0.000111	CbGpPWpGaD
Captopril—ABCB1—Metabolism—YAP1—ovarian cancer	9.02e-06	0.000109	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	8.95e-06	0.000109	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CDKN1B—ovarian cancer	8.9e-06	0.000108	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CASP3—ovarian cancer	8.72e-06	0.000106	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IL2—ovarian cancer	8.71e-06	0.000106	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—MAPK1—ovarian cancer	8.71e-06	0.000106	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—EGFR—ovarian cancer	8.71e-06	0.000106	CbGpPWpGaD
Captopril—ALB—Hemostasis—PIK3CB—ovarian cancer	8.57e-06	0.000104	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—YAP1—ovarian cancer	8.5e-06	0.000103	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCND1—ovarian cancer	8.49e-06	0.000103	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CTNNB1—ovarian cancer	8.41e-06	0.000102	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PIK3CD—ovarian cancer	8.4e-06	0.000102	CbGpPWpGaD
Captopril—ALB—Metabolism—FASN—ovarian cancer	8.39e-06	0.000102	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—PIK3CA—ovarian cancer	8.32e-06	0.000101	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	8.28e-06	0.0001	CbGpPWpGaD
Captopril—ALB—Metabolism—SLC5A5—ovarian cancer	8.25e-06	0.0001	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—KRAS—ovarian cancer	8.22e-06	9.98e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PTEN—ovarian cancer	8.2e-06	9.94e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	8.15e-06	9.89e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—SLC2A1—ovarian cancer	7.97e-06	9.66e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—IL2—ovarian cancer	7.87e-06	9.55e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	7.8e-06	9.46e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CYP1B1—ovarian cancer	7.64e-06	9.27e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—PIK3CA—ovarian cancer	7.56e-06	9.17e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ERBB2—ovarian cancer	7.42e-06	9e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—VEGFA—ovarian cancer	7.4e-06	8.98e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—FASN—ovarian cancer	7.35e-06	8.91e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—STAT3—ovarian cancer	7.33e-06	8.89e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MTOR—ovarian cancer	7.32e-06	8.88e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PIK3CB—ovarian cancer	7.32e-06	8.88e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NRAS—ovarian cancer	7.31e-06	8.87e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—SLC5A5—ovarian cancer	7.23e-06	8.77e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CXCL8—ovarian cancer	7.04e-06	8.54e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MAPK3—ovarian cancer	7e-06	8.49e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—HRAS—ovarian cancer	6.99e-06	8.48e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—SLC2A1—ovarian cancer	6.98e-06	8.47e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—FASN—ovarian cancer	6.93e-06	8.4e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CDKN1B—ovarian cancer	6.87e-06	8.34e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SLC5A5—ovarian cancer	6.81e-06	8.26e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MYC—ovarian cancer	6.81e-06	8.26e-05	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—AKT1—ovarian cancer	6.8e-06	8.25e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PPP2R1A—ovarian cancer	6.78e-06	8.22e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.74e-06	8.18e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CASP3—ovarian cancer	6.74e-06	8.17e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IL2—ovarian cancer	6.72e-06	8.16e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYP1B1—ovarian cancer	6.69e-06	8.12e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—IL6—ovarian cancer	6.69e-06	8.12e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—VEGFA—ovarian cancer	6.69e-06	8.11e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MAPK1—ovarian cancer	6.66e-06	8.08e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—EGFR—ovarian cancer	6.66e-06	8.08e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—NRAS—ovarian cancer	6.61e-06	8.01e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SLC2A1—ovarian cancer	6.58e-06	7.98e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCND1—ovarian cancer	6.56e-06	7.95e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CTNNB1—ovarian cancer	6.49e-06	7.87e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MMP9—ovarian cancer	6.36e-06	7.72e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—MAPK3—ovarian cancer	6.33e-06	7.68e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PTEN—ovarian cancer	6.33e-06	7.67e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CYP1B1—ovarian cancer	6.31e-06	7.65e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—KRAS—ovarian cancer	6.29e-06	7.63e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ABCB1—ovarian cancer	6.29e-06	7.63e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—TYMS—ovarian cancer	6.18e-06	7.49e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—AKT1—ovarian cancer	6.17e-06	7.49e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—MAPK1—ovarian cancer	6.02e-06	7.3e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PPP2R1A—ovarian cancer	5.94e-06	7.2e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PIK3CA—ovarian cancer	5.78e-06	7.01e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—VEGFA—ovarian cancer	5.72e-06	6.93e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—KRAS—ovarian cancer	5.69e-06	6.9e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—STAT3—ovarian cancer	5.66e-06	6.86e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NRAS—ovarian cancer	5.65e-06	6.85e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	5.59e-06	6.79e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TP53—ovarian cancer	5.59e-06	6.78e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—TYMS—ovarian cancer	5.41e-06	6.57e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MAPK3—ovarian cancer	5.41e-06	6.56e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—HRAS—ovarian cancer	5.35e-06	6.49e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MYC—ovarian cancer	5.26e-06	6.38e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—PIK3CA—ovarian cancer	5.22e-06	6.34e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ABCB1—ovarian cancer	5.19e-06	6.3e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MAPK1—ovarian cancer	5.14e-06	6.24e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—EGFR—ovarian cancer	5.14e-06	6.24e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IL6—ovarian cancer	5.12e-06	6.21e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—TYMS—ovarian cancer	5.1e-06	6.19e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—TP53—ovarian cancer	5.05e-06	6.13e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CAV1—ovarian cancer	4.98e-06	6.04e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—KRAS—ovarian cancer	4.86e-06	5.89e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—HRAS—ovarian cancer	4.83e-06	5.86e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.76e-06	5.77e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—AKT1—ovarian cancer	4.72e-06	5.73e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PIK3CG—ovarian cancer	4.53e-06	5.5e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PIK3CA—ovarian cancer	4.46e-06	5.41e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CAV1—ovarian cancer	4.36e-06	5.29e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TP53—ovarian cancer	4.32e-06	5.24e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—AKT1—ovarian cancer	4.27e-06	5.18e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HRAS—ovarian cancer	4.13e-06	5.01e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CAV1—ovarian cancer	4.11e-06	4.99e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PIK3CD—ovarian cancer	3.99e-06	4.84e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PIK3CG—ovarian cancer	3.97e-06	4.82e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IL6—ovarian cancer	3.95e-06	4.79e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PIK3CG—ovarian cancer	3.74e-06	4.54e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—AKT1—ovarian cancer	3.65e-06	4.42e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PIK3CD—ovarian cancer	3.49e-06	4.24e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PIK3CB—ovarian cancer	3.47e-06	4.21e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PIK3CD—ovarian cancer	3.29e-06	3.99e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PIK3CB—ovarian cancer	3.04e-06	3.69e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PTEN—ovarian cancer	3e-06	3.64e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PIK3CB—ovarian cancer	2.87e-06	3.48e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PTEN—ovarian cancer	2.63e-06	3.19e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PTEN—ovarian cancer	2.48e-06	3.01e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PIK3CA—ovarian cancer	2.12e-06	2.57e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.86e-06	2.25e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PIK3CA—ovarian cancer	1.75e-06	2.12e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—AKT1—ovarian cancer	1.73e-06	2.1e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—AKT1—ovarian cancer	1.52e-06	1.84e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—AKT1—ovarian cancer	1.43e-06	1.73e-05	CbGpPWpGaD
